Diabetes insipidus in infants and children

Elizabeth Dabrowski*, Rachel Kadakia, Donald Zimmerman

*Corresponding author for this work

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Diabetes insipidus, the inability to concentrate urine resulting in polyuria and polydipsia, can have different manifestations and management considerations in infants and children compared to adults. Central diabetes insipidus, secondary to lack of vasopressin production, is more common in children than is nephrogenic diabetes insipidus, the inability to respond appropriately to vasopressin. The goal of treatment in both forms of diabetes insipidus is to decrease urine output and thirst while allowing for appropriate fluid balance, normonatremia and ensuring an acceptable quality of life for each patient. An infant's obligate need to consume calories as liquid and the need for readjustment of medication dosing in growing children both present unique challenges for diabetes insipidus management in the pediatric population. Treatment modalities typically include vasopressin or thiazide diuretics. Special consideration must be given when managing diabetes insipidus in the adipsic patient, post-surgical patient, and in those undergoing chemotherapy or receiving medications that alter free water clearance.

Original languageEnglish (US)
Pages (from-to)317-328
Number of pages12
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume30
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Diabetes Insipidus
Vasopressins
Nephrogenic Diabetes Insipidus
Urine
Neurogenic Diabetes Insipidus
Polydipsia
Sodium Chloride Symporter Inhibitors
Thirst
Polyuria
Water-Electrolyte Balance
Quality of Life
Pediatrics
Drug Therapy
Water
Therapeutics
Population

Keywords

  • diabetes insipidus
  • nephrogenic diabetes insipidus
  • polydipsia
  • polyuria
  • vasopressin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Dabrowski, Elizabeth ; Kadakia, Rachel ; Zimmerman, Donald. / Diabetes insipidus in infants and children. In: Best Practice and Research: Clinical Endocrinology and Metabolism. 2016 ; Vol. 30, No. 2. pp. 317-328.
@article{bc3299cf6e474c2ca18451535cb2a423,
title = "Diabetes insipidus in infants and children",
abstract = "Diabetes insipidus, the inability to concentrate urine resulting in polyuria and polydipsia, can have different manifestations and management considerations in infants and children compared to adults. Central diabetes insipidus, secondary to lack of vasopressin production, is more common in children than is nephrogenic diabetes insipidus, the inability to respond appropriately to vasopressin. The goal of treatment in both forms of diabetes insipidus is to decrease urine output and thirst while allowing for appropriate fluid balance, normonatremia and ensuring an acceptable quality of life for each patient. An infant's obligate need to consume calories as liquid and the need for readjustment of medication dosing in growing children both present unique challenges for diabetes insipidus management in the pediatric population. Treatment modalities typically include vasopressin or thiazide diuretics. Special consideration must be given when managing diabetes insipidus in the adipsic patient, post-surgical patient, and in those undergoing chemotherapy or receiving medications that alter free water clearance.",
keywords = "diabetes insipidus, nephrogenic diabetes insipidus, polydipsia, polyuria, vasopressin",
author = "Elizabeth Dabrowski and Rachel Kadakia and Donald Zimmerman",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.beem.2016.02.006",
language = "English (US)",
volume = "30",
pages = "317--328",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

Diabetes insipidus in infants and children. / Dabrowski, Elizabeth; Kadakia, Rachel; Zimmerman, Donald.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 30, No. 2, 01.03.2016, p. 317-328.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Diabetes insipidus in infants and children

AU - Dabrowski, Elizabeth

AU - Kadakia, Rachel

AU - Zimmerman, Donald

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Diabetes insipidus, the inability to concentrate urine resulting in polyuria and polydipsia, can have different manifestations and management considerations in infants and children compared to adults. Central diabetes insipidus, secondary to lack of vasopressin production, is more common in children than is nephrogenic diabetes insipidus, the inability to respond appropriately to vasopressin. The goal of treatment in both forms of diabetes insipidus is to decrease urine output and thirst while allowing for appropriate fluid balance, normonatremia and ensuring an acceptable quality of life for each patient. An infant's obligate need to consume calories as liquid and the need for readjustment of medication dosing in growing children both present unique challenges for diabetes insipidus management in the pediatric population. Treatment modalities typically include vasopressin or thiazide diuretics. Special consideration must be given when managing diabetes insipidus in the adipsic patient, post-surgical patient, and in those undergoing chemotherapy or receiving medications that alter free water clearance.

AB - Diabetes insipidus, the inability to concentrate urine resulting in polyuria and polydipsia, can have different manifestations and management considerations in infants and children compared to adults. Central diabetes insipidus, secondary to lack of vasopressin production, is more common in children than is nephrogenic diabetes insipidus, the inability to respond appropriately to vasopressin. The goal of treatment in both forms of diabetes insipidus is to decrease urine output and thirst while allowing for appropriate fluid balance, normonatremia and ensuring an acceptable quality of life for each patient. An infant's obligate need to consume calories as liquid and the need for readjustment of medication dosing in growing children both present unique challenges for diabetes insipidus management in the pediatric population. Treatment modalities typically include vasopressin or thiazide diuretics. Special consideration must be given when managing diabetes insipidus in the adipsic patient, post-surgical patient, and in those undergoing chemotherapy or receiving medications that alter free water clearance.

KW - diabetes insipidus

KW - nephrogenic diabetes insipidus

KW - polydipsia

KW - polyuria

KW - vasopressin

UR - http://www.scopus.com/inward/record.url?scp=84960532858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960532858&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2016.02.006

DO - 10.1016/j.beem.2016.02.006

M3 - Review article

C2 - 27156767

AN - SCOPUS:84960532858

VL - 30

SP - 317

EP - 328

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 2

ER -